EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19

[1] Based on an interim analysis of this study EMA issued advice on the use of sotrovimab for treating COVID-19 in May 2021.

(MKY)

You may also like

• Press remarks by the President of the Republic of Cyprus at the joint press conference with the Prime Minister of the Republic of Croatia, in Zagreb
• “Empowering Europe with AI: The European Commission AI-based Multilingual Services” event successfully held
• The President of the Republic of Cyprus met with the President of the European Council
• The Minister of Foreign Affairs of the Republic of Cyprus had a meeting with the Prime Cabinet Secretary and Cabinet Secretary for Foreign and Diaspora Affairs of the Republic of Kenya
• Statement by the Minister of Foreign Affairs of the Republic of Cyprus, Mr Constantinos Kombos, after his meeting with the Federal Minister of European and International Affairs of the Republic of Austria, Ms Beate Meinl-Reisinger